Cabergoline: an advance in dopaminergic therapy
- PMID: 7889603
- DOI: 10.1111/j.1365-2265.1994.tb02782.x
Cabergoline: an advance in dopaminergic therapy
Erratum in
- Clin Endocrinol (Oxf) 1995 Jul;43(1):43
Comment on
-
Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine.Clin Endocrinol (Oxf). 1994 Dec;41(6):821-6. doi: 10.1111/j.1365-2265.1994.tb02799.x. Clin Endocrinol (Oxf). 1994. PMID: 7889620 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
